Joris Rotmans

Background

About Joris Rotmans

Joris Rotmans is a professor of Internal Medicine, nephrologist and head of the Subdepartment of Nephrology of the Leiden University Medical Center (LUMC) in the Netherlands. He received his PhD in 2005 at University of Amsterdam on new therapeutic strategies for vascular access for hemodialysis. In 2008-2009, he did postdoctoral research on vascular tissue engineering at the Australian Institute of Bioengineering and Nanotechnology in Brisbane, Australia. Since 2010, he combines clinical work as internist-nephrologist with vascular and renal research at the Department of Nephrology of the LUMC. He is the chair of the Expertise Center Vascular Access at the LUMC. He was the principle investigator of the DialysisXS consortium, in which a novel method to generate in vivo engineered blood vessels was developed. He was the principle investigator of the LIPMAT trial, a multicenter, randomized clinical trial in the Netherlands in which the efficacy of liposomal prednisolone to enhance AVF maturation is evaluated. He received a prestigious VIDI grant from NWO that allowed him to expand his research group and to continue his research on vascular access for hemodialysis. Joris Rotmans is head of the division of Nephrology at LUMC, chair of the Thematic Working Group on Vascular Tissue Engineering of TERMIS and past-president of the Vascular Access Society. Since March 2024, he is co-founder and CSO of XS Innovations, a spin off from LUMC and TU Delft, that develops new medical devices to improve vascular access for hemodialysis.